1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Vivo Bio Tech Limited

Vivo Bio Tech Limited

VIVOBIOT.BO
Vivo Bio Tech LimitedIN flagBombay Stock Exchange
23.37
INR
-0.18
- -
409.15MMarket Cap

Total Valuation

Vivo Bio Tech Limited carries a market capitalization of 409.15M, placing it among publicly traded companies globally. Its enterprise value stands at 1.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap409.15M
Enterprise Value1.08B

Share Statistics

Vivo Bio Tech Limited currently has 22.19M shares outstanding.

Shares Outstanding22.19M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Vivo Bio Tech Limited trades at a trailing price-to-earnings ratio of 35.45. The price-to-sales ratio is 0.79, and the price-to-book ratio stands at 1.90.

PE Ratio35.45
PS Ratio0.79
PB Ratio1.90
P/TBV Ratio1.01
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Vivo Bio Tech Limited trades at an EV/EBITDA multiple of 9.99 and an EV/FCF ratio of 139.70. The EV/Sales ratio of 2.03 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.99 provides insight into valuation relative to core operating earnings.

EV / Sales2.03
EV / EBITDA9.99
EV / EBIT9.99
EV / FCF139.70

Financial Position

Vivo Bio Tech Limited maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 72.33, indicating elevated leverage, while an interest coverage ratio of 1.85 demonstrates limited ability to service its debt obligations.

Current Ratio0.94
Quick Ratio0.05
Debt / Equity72.33
Debt / EBITDA6.23
Interest Coverage1.85

Financial Efficiency

Vivo Bio Tech Limited posts a return on equity of -5.02 and a return on invested capital of -2.60.

Return on Equity (ROE)-5.02
Return on Assets (ROA)-1.06
Return on Invested Capital (ROIC)-2.60
Return on Capital Employed (ROCE)-4.00
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.02

Taxes

Over the trailing twelve months, Vivo Bio Tech Limited has paid 65.19M in income taxes, reflecting an effective tax rate of 135.53.

Income Tax65.19M
Effective Tax Rate135.53

Stock Price Statistics

Vivo Bio Tech Limited's stock has declined approximately -36.42546% over the past 52 weeks. The 50-day moving average sits at 25.63, while the 200-day moving average is 29.14.

Beta (5Y)N/A
52-Week Price Change-36.42546%
50-Day Moving Average25.63
200-Day Moving Average29.14
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Vivo Bio Tech Limited generated 533.35M in revenue and converted that into -17.09M in net income, yielding earnings per share of -0.85. EBITDA reached 108.22M, while operating income came in at 108.22M.

Revenue533.35M
Gross Profit452.08M
Operating Income108.22M
Pretax Income48.10M
Net Income-17.09M
EBITDA108.22M
EBIT108.22M
Earnings Per Share (EPS)-0.85

Balance Sheet

Vivo Bio Tech Limited holds 14.36M in cash and equivalents against 673.81M in total debt, resulting in a net debt position of 659.45M. Total book value stands at 221.91M, with working capital of -18.16M providing operational flexibility.

Cash & Cash Equivalents14.36M
Total Debt673.81M
Net Debt659.45M
Equity (Book Value)221.91M
Book Value Per Share11.08
Working Capital-18.16M

Margins

Vivo Bio Tech Limited operates with a gross margin of 84.76, reflecting its pricing power and cost economics. The operating margin of 20.29 and net profit margin of -3.20 provide insight into operational efficiency.

Gross Margin84.76
Operating Margin20.29
Pretax Margin9.02
Profit Margin-3.20
EBITDA Margin20.29

Stock Splits

Vivo Bio Tech Limited's most recent stock split took place on September 25, 2012 with a 10:1 split ratio.

Last Split Date9/25/2012
Split Ratio10:1

Scores

Vivo Bio Tech Limited posts an Altman Z-Score of 0.98, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.98